{
    "clinical_study": {
        "@rank": "158044", 
        "arm_group": {
            "arm_group_label": "Cohort"
        }, 
        "brief_summary": {
            "textblock": "This multicenter, prospective, observational study will evaluate the safety and efficacy of\n      Avastin (bevacizumab) in combination with chemotherapy as first-line treatment in patients\n      with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer in routine\n      clinical practice. Eligible patients will be followed for approximately 15 months."
        }, 
        "brief_title": "An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)", 
        "completion_date": {
            "#text": "August 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Ovarian Cancer", 
        "condition_browse": {
            "mesh_term": "Ovarian Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients, >/= 18 years of age\n\n          -  Advanced (FIGO stages IIIB, IIIC and IV) epithelial ovarian, fallopian tube or\n             primary peritoneal cancer not previously treated with chemotherapy\n\n          -  Initiating Avastin in combination with chemotherapy\n\n        Exclusion Criteria:\n\n          -  Contraindications, warnings and precautions for use as specified in the Avastin\n             Summary of Product Characteristics"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with advanced (FIGO stages IIIB, IIIC and IV) epithelial ovarian, fallopian tube,\n        or primary peritoneal cancer undergoing first-line treatment with chemotherapy and Avastin"
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01863693", 
            "org_study_id": "ML28570"
        }, 
        "intervention_browse": {
            "mesh_term": "Bevacizumab"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 5, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bath", 
                        "country": "United Kingdom", 
                        "zip": "BA1 3NG"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United Kingdom", 
                        "zip": "B18 7QH"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bradford", 
                        "country": "United Kingdom", 
                        "zip": "BD9 6RJ"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bristol", 
                        "country": "United Kingdom", 
                        "zip": "BS2 8ED"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Burton on Trent", 
                        "country": "United Kingdom", 
                        "zip": "DE13 0RB"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Colchester", 
                        "country": "United Kingdom", 
                        "zip": "CO3 3NB"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eastbourne", 
                        "country": "United Kingdom", 
                        "zip": "BN21 2UD"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Exeter", 
                        "country": "United Kingdom", 
                        "zip": "EX2 5DW"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guildford", 
                        "country": "United Kingdom", 
                        "zip": "GU2 7XX"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ipswich", 
                        "country": "United Kingdom", 
                        "zip": "IP4 5PD"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Keighley", 
                        "country": "United Kingdom", 
                        "zip": "BD20 6TD"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leeds", 
                        "country": "United Kingdom", 
                        "zip": "LS9 7TF"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "SW3 6JJ"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maidstone", 
                        "country": "United Kingdom", 
                        "zip": "ME16 0FS"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manchester", 
                        "country": "United Kingdom", 
                        "zip": "M2O 4BX"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Middlesborough", 
                        "country": "United Kingdom", 
                        "zip": "TS4 3BW"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Middlesex", 
                        "country": "United Kingdom", 
                        "zip": "HA6 2RN"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newport", 
                        "country": "United Kingdom", 
                        "zip": "PO30 5TG"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nottingham", 
                        "country": "United Kingdom", 
                        "zip": "NG5 1PB"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portsmouth", 
                        "country": "United Kingdom", 
                        "zip": "PO6 3LY"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sheffield", 
                        "country": "United Kingdom", 
                        "zip": "S10 2SJ"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Southampton", 
                        "country": "United Kingdom", 
                        "zip": "SO16 6YD"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stoke-on-Trent", 
                        "country": "United Kingdom", 
                        "zip": "ST4 6QG"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sutton", 
                        "country": "United Kingdom", 
                        "zip": "SM2 5PT"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Swansea", 
                        "country": "United Kingdom", 
                        "zip": "SA2 8QA"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torquay", 
                        "country": "United Kingdom", 
                        "zip": "TQ27AA"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Truro", 
                        "country": "United Kingdom", 
                        "zip": "TR1 3LJ"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wirral", 
                        "country": "United Kingdom", 
                        "zip": "L63 4JY"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wolverhampton", 
                        "country": "United Kingdom", 
                        "zip": "WV10 0QP"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "York", 
                        "country": "United Kingdom", 
                        "zip": "YO31 8HE"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_groups": "1", 
        "official_title": "AN OBSERVATIONAL STUDY OF AVASTIN\u00ae (BEVACIZUMAB) AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED OVARIAN CANCER", 
        "overall_contact": {
            "email": "global.rochegenentechtrials@roche.com", 
            "last_name": "Reference Study ID Number: ML28570 www.roche.com/about_roche/roche_worldwide.htm", 
            "phone": "888-662-6728 (U.S. Only)"
        }, 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Department of Health"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Progression-free survival, defined as time from first administration of first-line therapy to documented disease progression", 
                "safety_issue": "No", 
                "time_frame": "approximately 6 years"
            }, 
            {
                "measure": "Safety: Incidence of adverse events", 
                "safety_issue": "No", 
                "time_frame": "approximately 6 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01863693"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Overall survival, defined as time from first administration of first-line therapy to documented death", 
                "safety_issue": "No", 
                "time_frame": "approximately 6 years"
            }, 
            {
                "measure": "Objective response rate, defined as percentage of patients with complete or partial response according to local assessments", 
                "safety_issue": "No", 
                "time_frame": "approximately 6 years"
            }, 
            {
                "measure": "Quality of life: EQ-5D/EORTC questionnaires", 
                "safety_issue": "No", 
                "time_frame": "approximately 6 years"
            }, 
            {
                "measure": "Dosage/schedule/duration of Avastin therapy", 
                "safety_issue": "No", 
                "time_frame": "approximately 6 years"
            }, 
            {
                "measure": "Composition of first-line chemotherapy regimens: drugs/dosage/duration", 
                "safety_issue": "No", 
                "time_frame": "approximately 6 years"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}